Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/20/2008CA2686604A1 Spiro compounds for treatment of inflammatory disorders
11/20/2008CA2686546A1 Novel peptide inhibitors of hepatitis c virus replication
11/20/2008CA2686517A1 Azetidine derivatives and their use as prostaglandin e2 antagonists
11/20/2008CA2686511A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008CA2686505A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
11/20/2008CA2686489A1 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008CA2686402A1 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
11/20/2008CA2686394A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008CA2686091A1 New compounds
11/20/2008CA2686043A1 Methods and compositions for heavy metal detoxification
11/20/2008CA2686035A1 Robust rapid disintegration tablet formulation
11/20/2008CA2685994A1 Single-chain circular rna and method of producing the same
11/20/2008CA2685888A1 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/20/2008CA2685861A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/20/2008CA2685860A1 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
11/20/2008CA2685761A1 New solid forms of fxa inhibitors
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008CA2685753A1 Bicyclic pyrimidine derivatives as calcium channel blockers
11/20/2008CA2685570A1 Therapeutic compounds
11/20/2008CA2685520A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008CA2685460A1 A liquid formulation for administering nicotine
11/20/2008CA2685456A1 Coated oral nicotine formulation buffered with amino acid
11/20/2008CA2685452A1 Oral nicotine formulation buffered with amino acid
11/20/2008CA2685380A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008CA2685379A1 Axomadol for treating pain from arthritis
11/20/2008CA2685351A1 Inhibitors of protein kinases
11/20/2008CA2685054A1 Agent for treatment of pulmonary disease
11/20/2008CA2685043A1 Use of iron chelator for the treatment of myocardial infarction
11/20/2008CA2684932A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/20/2008CA2684666A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/20/2008CA2684563A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008CA2684404A1 Novel piperazine salts as d3/d2 antagonists
11/20/2008CA2684114A1 Use of hdac inhibitors for the treatment of melanoma
11/20/2008CA2683941A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
11/20/2008CA2683195A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/20/2008CA2678335A1 Solid forms of a raf kinase inhibitor
11/20/2008CA2673133A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008CA2670694A1 Soft gel formulations
11/20/2008CA2669330A1 Methods and compositions for treating influenza
11/20/2008CA2667447A1 Mapk/erk kinase inhibitors
11/20/2008CA2667297A1 Oligoribonucleotides and uses thereof
11/20/2008CA2666537A1 P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-.beta.-d-ribofuranosyl)-3h-thiazole[4,5-d]pyrimidine-2-one and methods for preparation
11/20/2008CA2655846A1 5-htp combination therapy
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992645A1 Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition and food composition each using same
11/19/2008EP1992634A1 Oligonucleotide n3'- p5' thiophosphoramidates: their synthesis and use
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992629A1 Preparation of levofloxacin and forms thereof
11/19/2008EP1992625A1 Arylamide pyrimidone compounds
11/19/2008EP1992624A1 Heteroarylamide pyrimidone compounds
11/19/2008EP1992623A1 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
11/19/2008EP1992622A1 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1992620A1 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1992618A1 Polycyclic cinnamide derivative
11/19/2008EP1992610A1 New route of synthesis
11/19/2008EP1992363A1 Transdermal absorption preparation
11/19/2008EP1992361A1 Remedy or preventive for digestive ulcer
11/19/2008EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent
11/19/2008EP1992356A2 Rapamycin and IL-10 for the treatment of immune diseases
11/19/2008EP1992354A1 Rheumatoid arthritis-preventive agent for oral intake
11/19/2008EP1992350A2 Medical composition comprising a polysaccharide for elevating the epithelium
11/19/2008EP1992349A1 CGRP antagonists, their preparation and use as a medicament
11/19/2008EP1992348A1 Pharmaceutical combination
11/19/2008EP1992347A1 Treatment of DDR1 positive cancer using imatinib
11/19/2008EP1992346A1 Pharmaceutical compositions containing combined platelet aggregation inhibiting substances for use in the treatment and prevention of ischemic vascular events
11/19/2008EP1992345A1 Synergic combination of h2-receptor inhibitors, inert silicone and a hydroxymagnesium aluminate complex
11/19/2008EP1992344A1 P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
11/19/2008EP1992343A1 Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
11/19/2008EP1992342A1 Minimizing adverse experience associated with oxybutynin therapy
11/19/2008EP1992341A1 New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
11/19/2008EP1992340A1 Improved ophthalmic and contact lens solution
11/19/2008EP1992339A1 Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
11/19/2008EP1992338A2 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
11/19/2008EP1992337A1 Novel modified release composition and use
11/19/2008EP1992335A1 Spray drying methods and compositions thereof
11/19/2008EP1992334A1 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
11/19/2008EP1992333A1 Flurbiprofen and muscle relaxant combinations
11/19/2008EP1991710A2 Method for screening hiv drug sensitivity
11/19/2008EP1991692A2 Method and reagents for treating hepatic fibrosis and inflammation
11/19/2008EP1991678A2 Compositions and methods for oligonucleotide formulations
11/19/2008EP1991673A2 Method and apparatus for acne treatment using low intensity light therapy
11/19/2008EP1991587A2 Hydrazido derivatives of hyaluronic acid
11/19/2008EP1991559A2 Oxa-steroids derivatives as selective progesterone receptor modulators
11/19/2008EP1991557A1 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome
11/19/2008EP1991554A1 Thiopyrophosphate organic compounds, method for preparing thereof and compositions containing them
11/19/2008EP1991551A1 Meridamycin analogues for the treatment of neurodegenerative disorders
11/19/2008EP1991550A1 Amino pyrimidine compounds for the treatment of inflammatory disorders
11/19/2008EP1991549A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
11/19/2008EP1991548A1 Salt of cd 80 antagonist
11/19/2008EP1991547A2 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
11/19/2008EP1991545A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
11/19/2008EP1991544A2 Substituted imidazole derivatives and their use as ptpase inhibitors
11/19/2008EP1991543A1 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors
11/19/2008EP1991541A2 Novel pyrone-indole derivatives and process for their preparation
11/19/2008EP1991540A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/19/2008EP1991539A1 New salts of an indole derivative and their use in medicine
11/19/2008EP1991538A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
1 ... 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 ... 7860